NEW YORK – Boeing Co. gained 1.57% to close at $212.15 on Wednesday, September 3, 2026, as the Dow Jones Industrial Average recovered 295 points to 53,061.95. Among Boeing’s Dow peers, Apple rose 1.96% on iPhone 17 record revenue, Amgen surged 2.94% on its obesity drug pipeline, Alphabet gained 0.61% on antitrust relief, and American Express added 1.84% on premium card spending, while Amazon fell 2.32% on retail concerns and 3M eased 0.93%. The Boeing move was modest by the standards of Wednesday’s broader index session, but its direction reflected a market that has been slowly, grudgingly upgrading its assessment of a company whose turnaround story has been damaged by so many false starts that even legitimate operational progress is met with skepticism.
The progress is real this time. Boeing Commercial Airplanes delivered 171 aircraft in the second quarter of 2026, up 14% year over year and the highest quarterly delivery total since 2018, the year before the 737 MAX crisis effectively halted the company’s production momentum. Segment revenue from commercial airplanes rose 8% to $11.75 billion in the quarter, according to the company’s July 28 second-quarter results, and the company booked 246 net commercial orders, adding to what is now a $597 billion total backlog, a record figure.
A $597 billion backlog is a different kind of business asset than a quarterly revenue figure. It represents years of guaranteed production demand; the specific number varies by production rate, but at current volumes it represents roughly eight to ten years of manufacturing capacity. For a company that has spent the better part of six years convincing airlines, investors, and regulators that its quality and safety systems are reliable, a record backlog is the clearest market vote that the commercial aviation industry has made its decision: Boeing is the alternative to Airbus, and it will remain the alternative regardless of the reputational damage of the past decade.
The 737 program’s production trajectory is the operational variable that matters most. Boeing began transitioning the 737 line to 47 aircraft per month in the second quarter, a rate increase that, if sustained without the quality escapes and supplier disruptions that have derailed previous ramp-up attempts, would add meaningful revenue and cash flow over the next twelve to eighteen months. The company’s stated target is 57 per month by the end of 2027, which would put it back near the pre-MAX-crisis production levels that generated the cash flows supporting its investment-grade credit rating.
The path to 57 per month is not guaranteed. Spirit AeroSystems, Boeing’s largest fuselage supplier, has been working through its own quality and capacity issues, and the integration of Spirit (Boeing has been in the process of reacquiring the supplier it spun off in 2005) adds transition risk to a production system that has little margin for disruption. The question heading into the second half of 2026 is whether the 737 ramp can proceed without a significant quality event that would again trigger FAA scrutiny and production pauses.
Defense remains Boeing’s other major revenue segment, and it has been the more consistent performer through the commercial turnaround period. The company’s defense backlog includes long-cycle programs, including the KC-46 tanker, the F/A-18 Super Hornet in its final production years, and several classified programs, that generate revenue on multi-year schedules regardless of commercial market conditions. Defense revenue in the second quarter was stable, providing a floor under total company earnings while commercial volumes recover.
At $212.15, Boeing trades at a multiple that reflects the gap between current cash generation and the cash generation potential of the company at its production targets. The company is not yet generating the free cash flow that would justify a premium multiple; it has been cash flow negative or marginally positive for most of the past six years. The investment thesis is that production normalization, combined with the existing backlog, will convert to sustained positive free cash flow by 2027, at which point the current stock price will look inexpensive.
Whether that timeline holds depends on a production ramp that has failed to hold its schedule five times since 2019. The market’s response to Wednesday’s session, a 1.57% gain in a broadly rising day, suggests it is pricing probability, not certainty.
